Peptide antagonist of interleukin-15 activity

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/06 (2006.01) A61K 38/08 (2006.01) A61P 35/00 (2006.01) A61P 37/06 (2006.01) C12N 15/09 (2006.01)

Patent

CA 2738744

The present invention is related to the field of molecular immunology, particularly to a peptide derived from the sequence of interleukine-15 (IL-15), wherein said peptide was optimized to inhibit the biological activity of this molecule. In the present invention, it is shown that this peptide inhibits IL-15-induced T cell proliferation, Tumor Necrosis Factor a(TNF.alpha.) induction and the expression of IL-8 and IL-6 by the IL-15 receptor .alpha. subunit (IL-15R.alpha.), all these effects mediated by the binding of the peptide to the IL-15R.alpha.. The invention is also related to the use of the peptide to treat pathologies where the abnormal expression of IL-15 or IL-15R.alpha. is related to the course of the disease, such as rheumatoid arthritis (RA) and prostate cancer.

La présente invention concerne le domaine de la pharmacologie moléculaire, et notamment un peptide dérivé de la séquence de l'interleukine-15 (IL-15), optimisé pour inhiber l'activité biologique de cette molécule. Dans la présente invention, on démontre que ce peptide, lorsqu'il s'unit à la sous-unité alpha du récepteur (IL-15a), inhibe la prolifération de cellules T induite par l'IL-15, l'induction de facteur de nécrose tumorale a (TNFa) par l'IL-15, et l'expression de l'IL-8 et de l'IL-6 par l'IL-15Ra. L'invention concerne également l'utilisation dudit peptide pour traiter des pathologies dans lesquelles l'expression anormale de l'IL-15 ou de l'IL-15Ra est associée au développement d'une maladie, telle que l'arthrite rhumatoïde (AR) et le cancer de la prostate.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peptide antagonist of interleukin-15 activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide antagonist of interleukin-15 activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide antagonist of interleukin-15 activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1511350

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.